Article Text

Download PDFPDF
LMA was not superior to face-mask ventilation for neonatal resuscitation in term and later preterm infants born in Uganda
  1. Ayaz Ahmed,
  2. Joyce E O'Shea
  1. NICU, Royal Hospital for Children, Glasgow, UK
  1. Correspondence to Dr Ayaz Ahmed, NICU, Royal Hospital for Children, Glasgow, UK; ayaz.ahmed{at}ggc.scot.nhs.uk

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Study design: Superiority randomised controlled trial.

Allocation: Cluster randomisation with face mask or laryngeal mask airway (LMA).

Blinding: Unblinded.

Setting: Single-site maternity hospital in Uganda.

Patients: Babies born in hospital requiring positive pressure ventilation with gestational age of 34 weeks and weight of greater than 2 kg. Exclusion criteria include stillbirths and infants with major malformations affecting airways or incompatible with life.

Intervention: Resuscitation by a midwife with face mask or LMA.

Outcomes: The primary outcomes were neonatal intensive care unit (NICU) admission with moderate to severe hypoxic ischaemic encephalopathy (HIE) on days 1–5 of hospitalisation and composite of neonatal death within 7 days. The secondary outcomes included the need for advanced resuscitation, very early neonatal death within 24 hours of life, early neonatal death within 7 days, any hospital admission during …

View Full Text

Footnotes

  • Review of article Pejovic, Nicolas J., et al. A randomised trial of laryngeal mask airway in neonatal resuscitation. NEJM 2020;383;2138-47.

  • Twitter @ayaz74382348, @oshea_jem

  • Contributors AA wrote the abstract and commentary. JEO edited the commentary.

  • Provenance and peer review Not commissioned; internally peer reviewed.